Document is current
Any future updates will be listed below
-
Authors
Frigyesi, Attila https://orcid.org/0000-0002-0155-4828
Lengquist, Maria
Spångfors, Martin
Annborn, Martin
Cronberg, Tobias
Nielsen, Niklas
Levin, Helena
Friberg, Hans
-
Funding
Funding for this research was provided by:
Government funding of clinicalresearch within the Swedish National Health Services (2019:YF0053)
Regional Research Support
Biobanking and BioMolecular resources ResearchInfrastructure
Hans-Gabriel and Alice Trolle-Wachtmeister Foundation for Medical Research;
European UnionInterreg programme IV A
- License Information
-
More Information
Article History
Received: 26 April 2021
Accepted: 16 June 2021
First Online: 24 August 2021
Declarations
:
: The study was approved by the Regional Ethical Committee in Lund, Sweden, with reference numbers DNR 2015/267 and DNR 2017/802.
: Not applicable.
: The authors declare that they have no conflict of interest. Circulating dipeptidyl peptidase 3 was analysed free of charge by SphingoTec GmbH, Neuendorfstraße 15A, 16761 Hennigsdorf, Germany. The authors have no financial or any other interests in SphingoTec GmbH and have not been in any way influenced by the company in writing this research paper.
